{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:22:03Z","timestamp":1785252123736,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003443","name":"Ministry of Education and Science of the Russian Federation","doi-asserted-by":"publisher","award":["075-03-2023-642"],"award-info":[{"award-number":["075-03-2023-642"]}],"id":[{"id":"10.13039\/501100003443","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ejmech.2023.115296","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:22:52Z","timestamp":1679444572000},"page":"115296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["C(21)-fluorinated thevinol scaffold for opioid ligands. 21,21,21-Trifluoro-6-O-nororvinols: Design, synthesis and analgesic activity"],"prefix":"10.1016","volume":"252","author":[{"given":"Irina V.","family":"Sandulenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina V.","family":"Belozertseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin E.","family":"Zvartau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Zelentsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmik A.","family":"Ambartsumyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander F.","family":"Smol'yakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9104-8725","authenticated-orcid":false,"given":"Sergey K.","family":"Moiseev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115296_bib1","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1021\/ja00989a031","article-title":"Novel analgesics and molecular rearrangements in the morphine-thebaine group. II. Alcohols derived from 6,14-endo-etheno- and 6,14-endo-ethanotetrahydrothebaine","volume":"89","author":"Bentley","year":"1967","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115296_bib2","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.3390\/molecules27092863","article-title":"Diels-Alder adducts of morphinan-6,8-dienes and their transformations","volume":"27","author":"Marton","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115296_bib3","series-title":"Research and Development of Opioid-Related Ligands","first-page":"127","article-title":"Buprenorphine and related orvinols","author":"Husbands","year":"2013"},{"key":"10.1016\/j.ejmech.2023.115296_bib4","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2174\/1381612043453027","article-title":"Orvinols and related opioids - high affinity ligands with diverse efficacy profiles","volume":"10","author":"Lewis","year":"2004","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2023.115296_bib5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1039\/B610213C","article-title":"Fluorine in medicinal chemistry","volume":"37","author":"Purser","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2023.115296_bib6","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Application of fluorine in medicinal chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115296_bib7","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1021\/acs.chemrev.5b00392","article-title":"Next generation of fluorine-containing pharmaceuticals, compounds currently in phase II-III clinical trials of major pharmaceutical companies: new structural trends and therapeutic areas","volume":"116","author":"Zhou","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2023.115296_bib8","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1021\/acs.jmedchem.7b01788","article-title":"Fluorine and fluorinated motifs in the design and application of bioisosteres for drug design","volume":"61","author":"Meanwell","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115296_bib9","series-title":"Bioorganic and Medicinal Chemistry of Fluorine","author":"Begue","year":"2008"},{"key":"10.1016\/j.ejmech.2023.115296_bib10","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1016\/j.bmcl.2005.07.025","article-title":"Trifluoromethyl group as a pharmacophore: effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand","volume":"15","author":"Betageri","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115296_bib11","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1039\/D0OB00619J","article-title":"Fluorinated and [18F]fluorinated morphinan based opioid ligands","volume":"18","author":"Sandulenko","year":"2020","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2023.115296_bib12","doi-asserted-by":"crossref","first-page":"7956","DOI":"10.1016\/j.bmc.2008.07.065","article-title":"Design and synthesis of a metabolically stable and potent antitussive agent, a novel \u03b4 opioid receptor antagonist, TRK-851","volume":"16","author":"Sakami","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115296_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bmcl.2012.10.100","article-title":"The effect of 17-N substituents on the activity of the opioid \u03ba receptor in nalfurafine derivatives","volume":"23","author":"Nemoto","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115296_bib14","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1016\/j.bmc.2013.10.032","article-title":"The most effective influence of 17-(3-ethoxypropyl) substituent on the binding affinity and the agonistic activity in KNT-127 derivatives, \u03b4 opioid receptor agonists","volume":"21","author":"Nemoto","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115296_bib15","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/j.bmcl.2015.05.038","article-title":"Naltrindole derivatives with fluorinated ethyl substituents on the 17-nitrogen as \u03b4 opioid receptor inverse agonists","volume":"25","author":"Nemoto","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115296_bib16","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1021\/jm1013693","article-title":"Synopsis of some recent tactical application of bioisosteres in drug design","volume":"54","author":"Meanwell","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115296_bib17","first-page":"175","article-title":"Design, synthesis, and biological evaluation of C6-difluoromethylenated epoxymorphinan Mu opioid receptor antagonists","volume":"13","author":"Kassick","year":"2022","journal-title":"RCS Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115296_bib18","first-page":"258","article-title":"Reaction of thebaine with trifluoromethyl substituted acetylenic dienophiles","volume":"11","author":"Jeong","year":"1990","journal-title":"Bull. Kor. Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115296_bib19","first-page":"178","article-title":"Unexpected effect of fluorine in Diels-Alder reaction of 2-fluoroacrolein with thebaine","volume":"11","author":"Jeong","year":"1990","journal-title":"Bull. Kor. Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115296_bib20","first-page":"125","article-title":"Hetero Diels-Alder reaction of thebaine with perfluoroaldehydes and chemical transformation of their adducts","volume":"12","author":"Jeong","year":"1991","journal-title":"Bull. Kor. Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115296_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jfluchem.2016.07.015","article-title":"Reactions of thebaine derivatives with trifluoroacetyl acetylenes: [4+2]-addition solely","volume":"189","author":"Sandulenko","year":"2016","journal-title":"J. Fluor. Chem."},{"key":"10.1016\/j.ejmech.2023.115296_bib22","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1021\/jm990951r","article-title":"Structural determinants of opioid activity in the orvinols and related structures: ethers of orvinol and isoorvinol","volume":"43","author":"Coop","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115296_bib23","first-page":"136","author":"Lenz","year":"1986"},{"key":"10.1016\/j.ejmech.2023.115296_bib24","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1021\/ja00537a036","article-title":"Steric effects. A study of a rationally designed system","volume":"102","author":"Bott","year":"1980","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115296_bib25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1248\/cpb.39.233","article-title":"The steric effect of a trifluoromethyl group","volume":"39","author":"Nagai","year":"1991","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2023.115296_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/dmd.105.006148","article-title":"Novel metabolites of buprenorphine detected in human liver microsomes and human urine","volume":"34","author":"Chang","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2023.115296_bib27","series-title":"Novel Analgesics and Molecular Rearrangements in the Morphine-Thebaine Group. Part XVI. Some Derivatives of 6,14-Endo-Etheno-7,8-Dihydromorphine","first-page":"2569","author":"Bentley","year":"1969"},{"key":"10.1016\/j.ejmech.2023.115296_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112145","article-title":"Synthesis, biochemical, pharmacological characterization and in silico profile modelling of highly potent opioid orvinol and thevinol derivatives","volume":"191","author":"Sz\u0171cs","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115296_bib29","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/slct.201600233","article-title":"21,21,21-Trifluorothevinone: the straightest way to fluorinated thevinols and orvinols","volume":"1","author":"Sandulenko","year":"2016","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2023.115296_bib30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mencom.2022.01.031","article-title":"19F NMR determination of the C20 absolute configuration of C21-fluorinated arylthevinols","volume":"32","author":"Zelentsova","year":"2022","journal-title":"Mendeleev Commun."},{"key":"10.1016\/j.ejmech.2023.115296_bib31","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1039\/D2OB02144G","article-title":"Control of the diastereoselectivity at C(20) in the formation of C(21)-fluorinated thevinols","volume":"21","author":"Sandulenko","year":"2023","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2023.115296_bib32","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1021\/ja00989a030","article-title":"Novel analgesics and molecular rearrangements in the morphine-thebaine group. I. Ketones derived from 6,14-endo-ethenotetrahydrothebaine","volume":"89","author":"Bentley","year":"1967","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115296_bib33","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/BF00813809","article-title":"Herstellung von 6,14-ethenomorphinan-derivaten","volume":"125","author":"Marton","year":"1994","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.ejmech.2023.115296_bib34","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1021\/cn4000428","article-title":"Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed \u03bc agonist\/\u03b4 antagonist opioid analgesic with reduced tolerance liabilities","volume":"4","author":"Healy","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115296_bib35","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1021\/acs.jmedchem.5b00130","article-title":"C7\u03b2-methyl analogues of the orvinols: the discovery of kappa opioid antagonists with nociceptin\/orphanin FQ peptide (NOP) receptor partial agonism and low, or zero, efficacy at mu opioid receptors","volume":"58","author":"Cueva","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115296_bib36","series-title":"Manual on Laboratory Animals Use for Research and Training Purposes in Pavlov First Saint Petersburg State Medical University","first-page":"79","author":"Belozertseva","year":"2014"},{"key":"10.1016\/j.ejmech.2023.115296_bib37","first-page":"1426","article-title":"Eine empfindliche biologische reaktion auf morphin","volume":"37","author":"Straub","year":"1911","journal-title":"DMW (Dtsch. Med. Wochenschr.)"},{"key":"10.1016\/j.ejmech.2023.115296_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2016.08.014","article-title":"Morphine-induced Straub tail reaction in mice treated with serotonergic compounds","volume":"791","author":"Belozertseva","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115296_bib39","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1523\/JNEUROSCI.23-32-10331.2003","article-title":"Buprenorphine-induced antinociception is mediated by \u03bc-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors","volume":"23","author":"Lutfy","year":"2003","journal-title":"J. Neurosci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423002623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423002623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:50:46Z","timestamp":1759330246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423002623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":39,"alternative-id":["S0223523423002623"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115296","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C(21)-fluorinated thevinol scaffold for opioid ligands. 21,21,21-Trifluoro-6-O-nororvinols: Design, synthesis and analgesic activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115296"}}